STOCK TITAN

Rule 144 filing details 87-share LH (NYSE: LH) stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of Laboratory Corporation of America Holdings (LH) common stock has filed a Rule 144 notice to sell 87 shares through Fidelity Brokerage Services on the NYSE, with an approximate sale date of 02/12/2026 and an aggregate market value of $25,266.54.

The 87 shares were acquired on 02/11/2026 via restricted stock vesting from the issuer as compensation. In the past three months, Jonathan Meltzer sold LH common stock in two transactions: 88 shares on 02/09/2026 for $24,246.64 and 91 shares on 02/10/2026 for $25,187.89.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the latest Rule 144 notice for LH disclose?

The notice discloses a planned sale of 87 shares of LH common stock on or about 02/12/2026. The shares are to be sold on the NYSE through Fidelity Brokerage Services for an aggregate market value of $25,266.54.

How were the 87 LH shares in the Rule 144 filing acquired?

The 87 LH shares were acquired on 02/11/2026 through restricted stock vesting from the issuer. The filing states the nature of the payment as compensation, indicating these shares represent an equity award that recently vested before the planned sale.

What recent LH stock sales are reported for Jonathan Meltzer?

The filing reports two recent LH common stock sales by Jonathan Meltzer. He sold 88 shares on 02/09/2026 for gross proceeds of $24,246.64 and 91 shares on 02/10/2026 for gross proceeds of $25,187.89, both listed as separate transactions.

On which exchange will the 87 LH shares be sold under Rule 144?

The 87 LH common shares covered by the Rule 144 notice are planned to be sold on the New York Stock Exchange. The transaction will be executed through Fidelity Brokerage Services, which is listed as the broker handling the sale.

What class of LH securities is covered by this Rule 144 filing?

The filing covers LH common stock as the class of securities to be sold. It specifies that 87 common shares are intended for sale, with an aggregate market value of $25,266.54, and identifies the NYSE as the securities exchange.

How many LH shares are outstanding according to the Rule 144 notice?

The notice reports that 82,900,000 LH common shares are outstanding. This figure provides context for the 87-share planned sale, indicating the relative size of the transaction compared with the total shares outstanding.
Labcorp Holdings Inc

NYSE:LH

View LH Stock Overview

LH Rankings

LH Latest News

LH Latest SEC Filings

LH Stock Data

21.66B
81.91M
Diagnostics & Research
Services-medical Laboratories
Link
United States
BURLINGTON